Literature DB >> 14561622

Neurotoxicity of intrathecal methotrexate: MR imaging findings.

Claudio Sandoval1, Martin Kutscher, Somasundaram Jayabose, Michael Tenner.   

Abstract

We report a case of intrathecal methotrexate neurotoxicity manifesting as left arm weakness and aphasia. Diagnostic imaging showed restricted diffusion and fluid-attenuated inversion recovery imaging findings were normal at presentation. Three weeks later, diffusion abnormalities resolved, and T2-weighted studies showed increased signal intensity of prolonged T2 changes in areas of prior restricted diffusion. We attribute the clinical and radiographic findings to cytotoxic edema secondary to intrathecal methotrexate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561622      PMCID: PMC7976313     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer.

Authors:  C T Quinn; J C Griener; T Bottiglieri; K Hyland; A Farrow; B A Kamen
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

2.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

Authors:  D H Mahoney; J J Shuster; R Nitschke; S J Lauer; C P Steuber; N Winick; B Camitta
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

3.  Studies of cerebral blood flow in children with acute lymphoblastic leukemia: case reports of six children treated with methotrexate examined by single photon emission computed tomography.

Authors:  G Osterlundh; J Bjure; B Lannering; I Kjellmer; P Uvebrant; I Márky
Journal:  J Pediatr Hematol Oncol       Date:  1997 Jan-Feb       Impact factor: 1.289

4.  Assessment of brain perfusion by 99mTc-HMPAO SPECT in akinetic mutism due to high-dose intravenous methotrexate therapy.

Authors:  N I Karabacak; G Ozturk; K Gucuyener; N Gokcora; T Gursel
Journal:  Childs Nerv Syst       Date:  1997-10       Impact factor: 1.475

5.  Proton magnetic resonance spectroscopy ((1)H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer.

Authors:  A Davidson; G Payne; M O Leach; D McVicar; J M Britton; M Watson; D M Tait
Journal:  Med Pediatr Oncol       Date:  2000-07

6.  Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.

Authors:  L Lo Nigro; A Di Cataldo; G Schiliro
Journal:  Med Pediatr Oncol       Date:  2000-11

7.  Brain perfusion after treatment of childhood acute lymphoblastic leukemia.

Authors:  A H Harila-Saari; A K Ahonen; L K Vainionpää; E L Pääkkö; J Pyhtinen; A S Himanen; P J Torniainen; B M Lanning
Journal:  J Nucl Med       Date:  1997-01       Impact factor: 10.057

8.  Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity.

Authors:  Richard A Drachtman; Peter D Cole; Carla B Golden; S Jill James; Stepan Melnyk; Jospeh Aisner; Barton A Kamen
Journal:  Pediatr Hematol Oncol       Date:  2002 Jul-Aug       Impact factor: 1.969

  8 in total
  22 in total

1.  Acute pseudobulbar palsy due to methotrexate with rapid response to intravenous immunoglobulin.

Authors:  P Kinirons; A Fortune; H Enright; R P J Murphy
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

2.  MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings.

Authors:  E Kim; D G Na; E Y Kim; J H Kim; K R Son; K H Chang
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

Review 3.  Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings.

Authors:  P Mukherjee; J I Berman; S W Chung; C P Hess; R G Henry
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-13       Impact factor: 3.825

4.  Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.

Authors:  France Ziereisen; Bernard Dan; Nadira Azzi; Alina Ferster; Nash Damry; Catherine Christophe
Journal:  Pediatr Radiol       Date:  2005-12-21

5.  Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.

Authors:  M E Haykin; M Gorman; J van Hoff; R K Fulbright; J M Baehring
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

6.  Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.

Authors:  Me Haykin; M Gorman; J van Hoff; Rk Fulbright; Jm Baehring
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

7.  Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.

Authors:  W Küker; P Bader; U Herrlinger; S Heckl; T Nägele
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

8.  Magnetization transfer imaging provides no evidence of demyelination in methotrexate-induced encephalopathy.

Authors:  F R Miese; F R Schuster; K Pierstorff; M Karenfort; H J Laws; A Borkhardt; A Saleh
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-22       Impact factor: 3.825

Review 9.  Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature.

Authors:  Melissa Padovan; Luisa Maria Caniatti; Francesco Trotta; Marcello Govoni
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

10.  Case report: MRI of the brain in metronidazole toxicity.

Authors:  Vishal Kalia; Kavita Saggar
Journal:  Indian J Radiol Imaging       Date:  2010-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.